Apeloa Pharmaceutical Co., Ltd. (000739.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 23.01

From 52W high−16.06%

Volume15.74M

Market capCNY 22.83B

P/E (TTM)25.6x

P/S (TTM)2.9x

Div yield1.01%

Key dataSep 18, 2026

Open

CNY 23.01

From 52W high

−16.06%

Volume

15.74M

Market cap

CNY 22.83B

ValuationView details →

P/E (Fwd)

18.3x

EV/EBITDA

14.4x

P/E (TTM)

25.6x

RSI (14)

63.9

MomentumView details →

1D Return

−4.87%

YTD Return

+44.31%

ValuationView details →

P/E (Fwd)

18.3x

P/E (TTM)

25.6x

EV/EBITDA

14.4x

EV/Sales

2.6x

P/S (TTM)

2.9x

P/B (TTM)

3.5x

ProfitabilityView details →

Gross Margin

27.79%

Net Margin

9.38%

EBITDA Margin

18.34%

ROE (TTM)

13.58%

ROA (TTM)

7.27%

Asset Turnover

0.77x

GrowthView details →

Revenue YoY

−17.77%

EPS YoY

−12.99%

FCF YoY

+89.52%

Revenue CAGR 3Y

−2.47%

EPS CAGR 3Y

−2.86%

EBITDA YoY

—

MomentumView details →

1D Return

−4.87%

YTD Return

+44.31%

1Y Return

+42.39%

RSI (14)

63.9

vs 50D SMA

+9.67%

vs 200D SMA

+27.98%

Capital & dividendView details →

Debt/Equity

0.24x

Current Ratio

1.55x

Quick Ratio

1.28x

Div Yield

1.01%

Div Rate

CNY 0.24

Div Growth 1Y

+122.27%

EarningsView details →

EPS (Actual)

CNY 0.24

EPS Surprise

−17.24%

Beats (12Q)

0/12

Next Q EPS Est

CNY 0.34

Avg Surprise (4Q)

−17.24%

Rev Surprise

−0.96%

Financials snapshotView financials →

Revenue (TTM)

9.50B

Net Income (TTM)

891.15M

Op. CF (TTM)

1.36B

Next earningsOct 16, 2026 →

Latest newsMore news →

Apeloa Pharmaceutical's wholly-owned subsidiary Zhejiang Apeloa Debon Pharmaceutical Co., Ltd. received approval from the National Medical Products Administration for its Cefditoren pivoxil API, which is now approved for marketing and qualified for domestic market sales.11d ago

Puluo Pharmaceutical and others jointly established a new biotechnology company, Zhejiang Ante Yutai Biotechnology Co., Ltd., with registered capital of 10 million yuan.16d ago

Similar companies

博源化工000683.SZ 当升科技300073.SZ 博杰股份002975.SZ 中国重汽000951.SZ 赛微电子300456.SZ 托伦斯301583.SZ Find similar companies →

Latest newsMore news →

Apeloa Pharmaceutical's wholly-owned subsidiary Zhejiang Apeloa Debon Pharmaceutical Co., Ltd. received approval from the National Medical Products Administration for its Cefditoren pivoxil API, which is now approved for marketing and qualified for domestic market sales.11d ago Puluo Pharmaceutical and others jointly established a new biotechnology company, Zhejiang Ante Yutai Biotechnology Co., Ltd., with registered capital of 10 million yuan.16d ago Apeloa Pharmaceutical announced it will provide financial assistance of 255 million yuan to its subsidiary Zhejiang Ante Yutai Biotechnology Co., Ltd., with related party Hengdian Co., Ltd. contributing 245 million yuan, at an annualized interest rate of 3% for up to three years.17d ago